Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/03/2003EP1178953B1 Aromatic amides
12/03/2003EP1165184B1 Estrogen receptor-beta antagonism and bone diseases
12/03/2003EP1150963B1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
12/03/2003EP1140050B1 A composition useful to treat periodontal disease
12/03/2003EP1135383B1 Mixed paroxetine propan-2-ol solvates
12/03/2003EP1124813B1 Microbial transformation product
12/03/2003EP1119557B1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
12/03/2003EP1117659B1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
12/03/2003EP1112052B1 Method and device for producing tablets
12/03/2003EP1082304B1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)
12/03/2003EP1075483B1 Hygromycin a derivatives
12/03/2003EP1045709B1 Method and device for in-situ formulation of a medicinal solution for parenteral application
12/03/2003EP1027351B1 Phenanthroline derivatives
12/03/2003EP1027037B1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
12/03/2003EP0976748B1 Pyrrolidine derivatives having phospholipase a2 inhibitory activity
12/03/2003EP0971702B1 Microgranules containing cisplatin
12/03/2003EP0937070B1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
12/03/2003EP0915898B1 Crystal form i of clarithromycin
12/03/2003EP0874624B1 Hyaluronic acid receptors binding agents and their use for treating tumors or restenosis
12/03/2003EP0854715B1 Methods of inhibiting plasminogen activator inhibitor 1
12/03/2003EP0854705B1 Hormone dispenser for hormone replacement therapy method
12/03/2003EP0820280B1 Compositions for treating pain
12/03/2003EP0786455B1 Imidazole derivative
12/03/2003EP0767666B1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
12/03/2003EP0758233B1 Pde iv inhibitors for treating multiple sclerosis
12/03/2003EP0711158B1 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
12/03/2003CN1460109A Improved specificity in treatment of diseases
12/03/2003CN1460108A Water soluble rapamycin esters
12/03/2003CN1460105A 黄嘌呤磷酸二酯酶v抑制剂 Xanthine phosphodiesterase inhibitor v
12/03/2003CN1460104A Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1460100A Compounds and compositions for delivering active agents
12/03/2003CN1460099A Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/03/2003CN1460026A Compositions containing alpha-2-adrenergic agonist components
12/03/2003CN1460022A Extended type 1 chain glycosphingolipids as tumer-associated antigens
12/03/2003CN1460021A Plaster preparation
12/03/2003CN1460020A Pharmaceutical compositions containing aminothiazole derivatives for treatment of colonic motion dysfunctions
12/03/2003CN1460019A Improved injectable dispersions of propofol
12/03/2003CN1460018A Implantable gel compositions and method of mfg.
12/03/2003CN1460013A 局部凝胶给药体系 Topical gel delivery system
12/03/2003CN1459448A Preparation method of red sageroot total phenolic acid and its use
12/03/2003CN1459315A Biodegradation type introducing agent of hardly water-soluble steroid, nonsteroid anti-inflammatory medicine, and its prepn. method
12/03/2003CN1459314A Composition for preventing and treating milk cow from bateria disease
12/03/2003CN1459295A Traditional Chinese medicinal powder pasted on shenchueh acupoint for treating astriction
12/03/2003CN1459291A Eyedrops containing low molecular weight heparin, and its prepn. method
12/03/2003CN1459290A Antitussive and its prepn. process
12/03/2003CN1459289A Health-care food
12/03/2003CN1459288A Cyclophosphadenosine glucosamine infusion prepn., and its prepn. process, and method for testing contents thereof
12/03/2003CN1459287A Cytophosphocholine sodium quantitative drop
12/03/2003CN1459286A Tetrodotoxin respiratory tract administration prepn. used for giving-up drug and easing pain
12/03/2003CN1459285A Plaster for reunion of laceration of skin
12/03/2003CN1459284A Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method
12/03/2003CN1459283A Usage of basic bismuth gallate for preventing and/or lowering degradation of skin
12/03/2003CN1459282A Method for prodn. of water soluble fluorophenylnicol
12/03/2003CN1459281A Medicine for preventing or treating AIDS, and prepn. and application thereof
12/03/2003CN1459280A Usage of immunopotentiation by using resveratrol
12/03/2003CN1129646C Anionic cationic polyion complexes comprising zwitterionic monomer component
12/03/2003CN1129613C Oleander flower polysaccharide and its preparing method and use
12/03/2003CN1129612C Process for decolouring polyose and its health care food
12/03/2003CN1129608C Method and apparatus for preparing acellular red blood cell substitute
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives
12/03/2003CN1129599C Substituted benzothiazine/oxazine-2-amide derivatives, their prepn and application
12/03/2003CN1129598C Itraconazole with improved solubility, method of preparing same and pharmaceutical composition for oral administration comprising same
12/03/2003CN1129593C Method for prepn of citalopram
12/03/2003CN1129592C Method for preparation of citalopram
12/03/2003CN1129591C O-substituted hydroxycumaranone derivatives as antitumor and antimetastatic agents
12/03/2003CN1129582C 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
12/03/2003CN1129580C Method for crystallisation of tetrahydropyridin derive and resulting crystalline forms
12/03/2003CN1129579C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
12/03/2003CN1129578C Tetrahydrobenzindole derivs
12/03/2003CN1129577C 维生素d3衍生物 Derivatives of vitamin d3
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129572C Tanshinpolyphenolic salt mixture and preparation and application thereof
12/03/2003CN1129449C Pain treatnig composite medicine
12/03/2003CN1129445C Burn treating Chinese medicine prepn.
12/03/2003CN1129440C Preparing process for piles treating medicine
12/03/2003CN1129438C Bone strengthening and pus drawing out ointment
12/03/2003CN1129435C Germanium yeast human diet nutritional supplement
12/03/2003CN1129433C Use of formyl amine for preparing composition for treating lipsotrichia
12/03/2003CN1129432C Reducing toxic effects of carboplatin using dithioethers
12/03/2003CN1129431C Combination of benzocyclobeptapyridine compounds and antineoplastic drugs for treating proliferative diseases
12/03/2003CN1129430C Formulations for controlling human lice
12/03/2003CN1129429C Potassium sodium and tris oxaprozin salt pharmaceutical formulations
12/03/2003CN1129428C Endothelin receptor antagonists
12/03/2003CN1129427C TTS contg. antioxidant
12/03/2003CN1129426C Percutaneous absorption type preparation
12/03/2003CN1129425C Medicated tissue paper product
12/03/2003CN1129424C Ceramide lipsome emulsion contaniing Va and its preparing process and usage
12/03/2003CA2409795A1 Liposome preparation
12/02/2003US6657104 Cell-based, and whole-animal-based assays for detecting substances having therapeutic activity toward cardiac hypertrophy.
12/02/2003US6657086 For reducing weight in mammals; preventing and treating obesity
12/02/2003US6657064 For use as analgesics
12/02/2003US6657060 Neuropeptide Y antagonists; treatment of eating disorders such as obesity and hyperphagia
12/02/2003US6656973 Anticancer chemotherapy, and cytoprotective agents administered before, during or after chemotherapy to protect the normal cells of the patient
12/02/2003US6656972 Tetrahydrocannabinol; side effect reduction
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656970 Method and compositions for solubilization of pentacyclic triterpenes
12/02/2003US6656968 (Z)-styryl acetoxyphenyl sulfides as cyclooxygenase inhibitors
1 ... 5257 5258 5259 5260 5261 5262 5263 5264 5265 5266 5267 5268 5269 5270 5271 5272 5273 5274 5275 5276 5277 ... 7860